Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lv, Yongning
DA414, NCT06525168: Safety, Tolerability and Pharmacokinetic Characteristics Evaluation on	Recruiting	1	82	RoW	DA414 Granules, DA414, DA414 placebo, Placebo	Chendu DIAO Nine Hong Pharmaceutical Factory	Ischemic Stroke	09/25	09/26